Benzinga | Jul 28, 2021 08:50AM EDT

Fluidigm Stock Shoots Higher On Bloomberg Report Of Exploring Potential Sale

* Fluidigm Corp (NASDAQ:FLDM) stock is trading higher in the premarket on a report that the Company is considering a sale.

* According to a Bloomberg report, the medical technology firm is working with an adviser to see interest from possible buyers.

* The Company may garner interest from other healthcare providers and private equity firms.

* Fluidigm's laboratory equipment helps researchers analyze cells and genomes to target conditions like cancer and immune dysfunction.

* It released a COVID-19 saliva test that received emergency use authorization last August from the FDA.

* Price Action: FLDM shares are up 7.87% at $6.85 during the premarket session on the last check Wednesday